Publications by authors named "Amy L McLean"

Unlabelled: Infants born to mothers with intraamniotic infection (IAI) received antibiotic treatment per the Centers for Disease Control and Prevention and American Academy of Pediatrics guidelines in our neonatal intensive care unit (NICU) for early-onset bacterial sepsis evaluation. We conducted a quality improvement project to decrease antibiotic use and NICU admission in infants born to mothers with IAI.

Methods: We aimed to decrease the antibiotic exposure for asymptomatic infants born to mothers with IAI from 100% to 20% in 6 months.

View Article and Find Full Text PDF

Prosthetic breast implants are used frequently for both aesthetic and reconstructive purposes. Histologically, the normal tissue response to silicone implants typically involves an inflammatory infiltrate that consists initially of macrophages, and later consists of fibroblasts, myofibroblasts, and lymphocytes. To characterize further the nature of the inflammatory response to silicone breast implants, the authors evaluated the expression of the enzyme cyclooxygenase-2 (COX-2) by the tissues and cells of the breast capsule after silicone augmentation in an animal model.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Amy L McLean"

  • - Recent research by Amy L McLean focuses on improving neonatal care practices by reducing unnecessary antibiotic exposure in infants and assessing inflammatory responses related to prosthetic implants.
  • - In her 2021 study, McLean implemented a quality improvement project aimed at decreasing antibiotic use from 100% to 20% in asymptomatic infants born to mothers with intraamniotic infection, demonstrating a proactive approach to minimizing medication exposure.
  • - Additionally, her 2002 study explored the expression of cyclooxygenase-2 (COX-2) in response to silicone breast implants, contributing to a better understanding of the inflammatory process involved in surgical and implant procedures.